Featured image: original editorial packaging illustration, not a photograph of a tested or manufactured customer product.

Approved samples are the starting point for a commercial order, not a complete production instruction. Mouthwash, toothpaste and breath spray can share a brand identity while requiring different formulas, components, production routes and destination-market documents.

For established brands, importers and distributors, the next task is to freeze a controlled SKU list: what is being bought, in what quantity, against which approved revision, and with which issues still open. This guide covers the sample-to-order handover once the target markets and commercial purchasing requirements are defined.

Build the SKU master before combining purchase orders

Give every sellable finished item a unique SKU ID and define its unit: one finished bottle, tube, spray or sachet. Record formula and component revisions separately from the commercial SKU code. A change in formula, flavor, fill size or pack format may create a distinct SKU; a document or component revision needs an impact review even when the commercial SKU code stays the same.

The SKU master should connect product identity, market, quantity, approvals and open actions. Keep finished-goods MOQ separate from the minimum purchase quantities for bottles, closures and other components. The field guide below explains the main responsibilities; the example record shows how to carry them into an order handover.

Master field Why the buyer needs it Who should confirm it
Formula and scope Distinguishes approved bases, custom development and concepts still under feasibility review. Technical lead and manufacturing partner.
Primary package Identifies the bottle, tube, spray pump or single-use format actually proposed. Packaging engineer and component supplier.
Destination market Separates classification, claim and labeling work that may differ by territory. Brand and applicable local regulatory party.
Quality evidence Links trials and specifications to the released SKU revision. Quality and technical reviewers.
Order unit and pack-out Prevents carton quantities or mixed assortments from being mistaken for sellable units. Operations and commercial owner.
Release status Shows which items are ready to order and which remain conditional. Named approval authority.

Illustrative SKU handover record

This is a planning example, not a completed test report or verified customer order. Duplicate the record for each relevant SKU or test and agree the criteria, sample count and responsible reviewer before use.

Field Planning record / decision
SKU ID / category EXAMPLE-MW-01 / bottled cosmetic mouthwash — fictional planning identifier
Finished sellable unit One finished 250 mL bottle (illustrative format only; confirm actual fill and market)
Formula revision / fill size F-01 (placeholder) / 250 mL (illustrative); approved technical record: pending
Pack component revision / pack-out Bottle + closure P-01 (placeholder); carton configuration: to confirm
Destination / claims owner Target market and channel: to confirm; responsible brand/local claims reviewer: to assign
Units per SKU / order 10,000 finished bottles (MOQ planning example; no actual order or production commitment)
MOQ basis — finished goods Standard bottled-mouthwash MOQ: 10,000 finished units per SKU; do not pool flavors, formulas or sizes
MOQ basis — components Bottle/closure procurement quantities: to confirm separately with the component supplier
Sample / evidence status Prototype review and formula–pack evidence: pending; no production approval inferred
Lead time — initial Normally 45–60 calendar days only after formula, packaging, artwork and deposit confirmation and agreed scheduling
Lead time — repeat Generally plan 25–35 days, subject to unchanged approved specifications and confirmed schedule
Open issue / owner / due date Compatibility evidence not yet reviewed / Technical or Quality reviewer to assign / Date to agree
Release status HOLD — pending documented approvals; not authorized for commercial release

Distinguish shared branding from shared production assumptions

One design system can serve a product family, but it does not make production constraints interchangeable. For example, a tube-packed toothpaste concept may require a separate licensed-manufacturing feasibility review, whereas an established cosmetic mouthwash programme can have a different confirmation process. A breath spray adds pump and dispensing considerations. Ask for category-specific decisions rather than a single blanket promise.

Commercial minimums should be checked at the SKU and package-component level. A multi-pack may change its count without changing the formula; a custom closure can create a new purchasing constraint. Record the actual commercial assumptions and ask for explicit approval when the SKU list changes. For ORALABX programmes, the standard commercial MOQ is 10,000 units per SKU for bottled mouthwash, breath spray and toothpaste, and 100,000 units per SKU for individual mouthwash sachets. Quantities across different formulas, flavors or pack sizes should not be pooled to imply that each SKU meets its MOQ. Keep finished-goods MOQ and packaging-component procurement quantities in separate fields; any project exception requires written confirmation and is not a general site-wide offer.

Freeze specifications in stages

Scope freeze: agree the product categories, markets, intended claims and project feasibility status.

Formula freeze: identify the approved revision and unresolved stability or performance evidence.

Component freeze: approve the final product-contact packaging and the compatibility plan.

Artwork freeze: lock the correct pack design and destination-market labeling review.

Order freeze: verify SKU quantities, pack-out, commercial terms and the required release-document list. Check the date on which the lead-time clock may start and who confirms scheduling. Prototype samples typically take 5–7 working days; first production normally takes 45–60 calendar days after formula, packaging, artwork and deposit confirmation. Repeat supply is generally planned at 25–35 days, subject to the confirmed specification and schedule. Prototype preparation does not mean that stability, compatibility or market-specific reviews are complete.

Do not represent a stage as complete merely because the next team has started work. A conditional item should stay visible in the SKU master with its dependency, owner and expected decision.

Plan replenishment before the first shipment

Set a review point for repeat demand, component lead times and allowable substitution rules. If a second production run will use a different supplier, material or artwork revision, check whether the original evidence still applies. Keep first-order and repeat-order assumptions separate; an initial launch forecast is not a verified demand history. Any proposed change to the formulation, product-contact materials, supplier or filling conditions first requires a documented change-impact review before deciding whether earlier evidence may be carried forward. Record the handover decision here; the detailed requalification pathway belongs in the companion mouthwash change-control guide.

Use a change log with a short reason, affected SKUs, approval owner and evidence reference. The goal is not paperwork for its own sake. It is to prevent a convenient component swap or hurried label update from producing an unintended second product specification.

Keep supplier responsibilities explicit

Ask each partner to identify which information it can provide, which third-party tests or local filings require separate commissioning and who approves the finished product for the destination market. Avoid assuming that a manufacturer owns every regulatory task because it supplied the formula or packaging. The manufacturing partner supplies agreed manufacturing documentation; the brand, importer or appointed local responsible party manages applicable destination-market submissions. The permitted scope of disclosure and formula-use rights must follow the written project agreement, without assuming automatic transfer of the complete formula.

For a programme spanning several categories, a multi-category oral care manufacturing review can establish whether the proposed products share a feasible commercial route or need separate technical and licensing decisions. Toothpaste manufacturing commitments in particular should remain conditional until the current licensed arrangement and product scope are confirmed.

For stage-by-stage procurement and production handover, see the ORALABX OEM process overview. This supporting reference does not replace the project-specific licensed-route review for toothpaste.

The handover package for a reliable first order

A procurement-ready handover contains the controlled SKU master, approved revision-controlled specifications and artwork, the open-issue list, per-SKU finished quantities and component minima, evidence references and named release responsibilities. Submit the SKU master and open-issue list for project review and written decisions. Receiving prototype samples alone does not authorize production scheduling or commercial batch release; only the project’s applicable approvals can do that.

Planning an Oral Care OEM Project?

Share your product type, target market, estimated volume and launch timeline. We will review the project scope and recommend the appropriate development path.

Best suited to brands, importers and distributors planning scalable commercial production.